Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin for Candidemia in Asian Patients
NCT00537329Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 4
01
Overview
A Phase 3 trial of anidulafungin in candidemia, sponsored by Pfizer. Started Jan 2008; status: completed.
02
Drugs
anidulafungin
03
Conditions
candidemia
Beyond the preview
Go deeper on NCT00537329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537329.